Your browser doesn't support javascript.
loading
Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol.
Dambha-Miller, Hajira; Albasri, Ali; Hodgson, Sam; Wilcox, Christopher; Islam, Nazrul; Khan, Shareen; Little, Paul; Griffin, Simon.
Afiliação
  • Dambha-Miller H; NIHR Academic Clinical Lecturer and GP, Division of Primary Care and Population Health, University of Southampton, Southampton, UK.
  • Albasri A; Clinical Pharmacist and Research Fellow, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Hodgson S; NIHR Academic Clinical Fellow, Division of Primary Care and Population Health, University of Southampton, Southampton, UK samcbhodgson@gmail.com.
  • Wilcox C; NIHR Academic Clinical Fellow, Division of Primary Care and Population Health, University of Southampton, Southampton, UK.
  • Islam N; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Khan S; Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK.
  • Little P; Specialist Pharmacist, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Griffin S; Professor of Primary Care, Division of Primary Care and Population Health, University of Southampton, Southampton, UK.
BJGP Open ; 4(3)2020 Aug.
Article em En | MEDLINE | ID: mdl-32665234

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2020 Tipo de documento: Article